 | |
| Clinical data | |
|---|---|
| Trade names | Syncro-Mate B, Crestar |
| Other names | Norgestamet; SC-21009; 11β-Methyl-17α-acetoxy-19-norprogesterone; 17α-Hydroxy-11β-methyl-19-norpregn-4-ene-3,20-dione acetate |
| Drug class | Progestogen;Progestin;Progestogen ester |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.042.359 |
| Chemical and physical data | |
| Formula | C23H32O4 |
| Molar mass | 372.505 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Norgestomet, ornorgestamet, sold under the brand nameSyncro-Mate B andCrestar, is aprogestin medication which is used inveterinary medicine to controlestrus andovulation incattle.[1][2]
Norgestomet is used inveterinary medicine.
Norgestomet is aprogestogen. In addition to theprogesterone receptor, it possesses weak (micromolar)affinity for theglucocorticoid receptor.[3]
Norgestomet, also known as 11β-methyl-17α-acetoxy-19-norprogesterone or as 17α-hydroxy-11β-methyl-19-norpregn-4-ene-3,20-dione acetate, is asyntheticnorpregnanesteroid and aderivative ofprogesterone.[1][4]
Norgestomet was developed and introduced for veterinary use in the mid-1970s.[5]
Norgestomet is thegeneric name of the drug and itsINNTooltip International Nonproprietary Name,USANTooltip United States Adopted Name, andBANTooltip British Approved Name.[1][4] It also known asnorgestamet and is known by its developmental code name SC-21009.[1][4][6]
Norgestomet is marketed under the brand names Syncro-Mate B and Crestar.[1][4]